Literature DB >> 30511987

Vascularized Composite Allotransplantation: Alternatives and Catch-22s.

J Rodrigo Diaz-Siso1, Zachary M Borab, Natalie M Plana, Brendan Parent, John T Stranix, Eduardo D Rodriguez.   

Abstract

Technical success has been achieved in several forms of vascularized composite allotransplantation, including hand, face, penis, and lower extremity. However, the risks of lifelong immunosuppression have limited these procedures to a select group of patients for whom nontransplant alternatives have resulted in unsatisfactory outcomes. Recent reports of facial allograft failure, and subsequent reconstruction using autologous tissues, have reinforced the idea that a surgical contingency plan must be in place in case this devastating complication occurs. Interestingly, backup plans in the setting of vascularized composite allotransplantation consist of the nontransplant alternatives that were deemed suboptimal in the first place. Moreover, these options may have been exhausted before transplantation, and may therefore be limited in the case of allograft loss or reamputation. In this article, the authors describe the surgical and nonsurgical alternatives to hand, face, penis, and lower extremity transplantation. In addition, the authors explore the ethical implications of approaching vascularized composite allotransplantation as a "last resort" or as a "high-risk, improved-outcome" procedure, focusing on whether nontransplant options eventually preclude vascularized composite allotransplantation, or whether vascularized composite allotransplantation limits future nontransplant reconstruction.

Entities:  

Mesh:

Year:  2018        PMID: 30511987     DOI: 10.1097/PRS.0000000000004855

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  2 in total

1.  Video Messaging to Increase Vascularized Composite Allograft Donation Willingness in United States Military Veterans.

Authors:  James R Rodrigue; Jessica Shenkel; Matthew Boger; Bohdan Pomahac; Aaron Fleishman
Journal:  Transplant Direct       Date:  2022-09-16

2.  VCA in the Era of the COVID-19 Pandemic.

Authors:  Palmina Petruzzo; Jean Kanitakis; Claudia Sardu; Bahar Bassiri Gharb; Emmanuel Morelon; Hatem Amer; Juan Barret; James Burt; Gerald Brandacher; Tomas Gomez; Simon Kay; Dorotha Kaminska; Christina L Kaufman; Dinesh S Kumar; Martin Iglesias; Subramania Iyer; Luis Landin; Marco Lanzetta; Patrick Lassus; Scott Levin; Francis Papay; Bohdan Pomahac; Paolo Sassu; Nilesh G Satbhai; Simon Talbot
Journal:  Transplantation       Date:  2022-04-01       Impact factor: 5.385

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.